Overall, our findings illustrate that ASCL1, OLIG2, and SOX2 are coexpressed in tumor cells of both early and terminal tumors of the glioma mouse model in vivo, and tumor cells maintain a molecular identity reminiscent of that of OPCs. This evidence concerns the gene ASCL1 and central nervous system cancer.